chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 88.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: fatigue; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, ACETYLSALICYLIC ACID (ASPIRIN 81) and ATORVASTATIN for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. No treatment medications provided by the reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Hyperhidrosis, Illness
Clinical narrative: Traumatic experience; Lethargic/Not motivated; got very sick; Fever 100.5F; Chills; Pounding headache; swelling in the arm (Injection Site); Sweating; Trembling; This spontaneous case was reported by a health care professional and describes the occurrence of HYPERHIDROSIS (Sweating), TREMOR (Trembling), INJURY (Traumatic experience), LETHARGY (Lethargic/Not motivated) and ILLNESS (got very sick) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 15-Jan-2021.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced HYPERHIDROSIS (Sweating), TREMOR (Trembling), LETHARGY (Lethargic/Not motivated), ILLNESS (got very sick), PYREXIA (Fever 100.5F), CHILLS (Chills), HEADACHE (Pounding headache) and VACCINATION SITE SWELLING (swelling in the arm (Injection Site)). On an unknown date, the patient experienced INJURY (Traumatic experience). At the time of the report, HYPERHIDROSIS (Sweating), TREMOR (Trembling), INJURY (Traumatic experience), LETHARGY (Lethargic/Not motivated), ILLNESS (got very sick), PYREXIA (Fever 100.5F), CHILLS (Chills), HEADACHE (Pounding headache) and VACCINATION SITE SWELLING (swelling in the arm (Injection Site)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature: 100.5f (High) 100.5F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injury, Lethargy, Pyrexia, Tremor, Vaccination site swelling
Clinical narrative: Traumatic experience; Lethargic/Not motivated; got very sick; Fever 100.5F; Chills; Pounding headache; swelling in the arm (Injection Site); Sweating; Trembling; This spontaneous case was reported by a health care professional and describes the occurrence of HYPERHIDROSIS (Sweating), TREMOR (Trembling), INJURY (Traumatic experience), LETHARGY (Lethargic/Not motivated) and ILLNESS (got very sick) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 15-Jan-2021.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced HYPERHIDROSIS (Sweating), TREMOR (Trembling), LETHARGY (Lethargic/Not motivated), ILLNESS (got very sick), PYREXIA (Fever 100.5F), CHILLS (Chills), HEADACHE (Pounding headache) and VACCINATION SITE SWELLING (swelling in the arm (Injection Site)). On an unknown date, the patient experienced INJURY (Traumatic experience). At the time of the report, HYPERHIDROSIS (Sweating), TREMOR (Trembling), INJURY (Traumatic experience), LETHARGY (Lethargic/Not motivated), ILLNESS (got very sick), PYREXIA (Fever 100.5F), CHILLS (Chills), HEADACHE (Pounding headache) and VACCINATION SITE SWELLING (swelling in the arm (Injection Site)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature: 100.5f (High) 100.5F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Decreased appetite, Fatigue, Hyperhidrosis
Clinical narrative: loss of appetite; achy; lower back pain; cold sweats; Chills; tired; fever of 102; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arthritis and Hip replacement (two hip replacement.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats), CHILLS (Chills), FATIGUE (tired) and PYREXIA (fever of 102). On 01-Mar-2021, DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats), CHILLS (Chills), FATIGUE (tired) and PYREXIA (fever of 102) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No concomitant information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: loss of appetite; achy; lower back pain; cold sweats; Chills; tired; fever of 102; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arthritis and Hip replacement (two hip replacement.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats), CHILLS (Chills), FATIGUE (tired) and PYREXIA (fever of 102). On 01-Mar-2021, DECREASED APPETITE (loss of appetite), PAIN (achy), BACK PAIN (lower back pain), HYPERHIDROSIS (cold sweats), CHILLS (Chills), FATIGUE (tired) and PYREXIA (fever of 102) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No concomitant information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness around the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. In February 2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication details were not reported by the reporter. No treatment details were provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Eyelid thickening
Clinical narrative: Developed a little knot on the eye; This spontaneous case was reported by an other health care professional and describes the occurrence of EYELID THICKENING (Developed a little knot on the eye) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included GLIMEPIRIDE (AMARYL), PROGESTERONE, SPIRONOLACTONE, HYDROXYCHLOROQUINE, CEVIMELINE and THYROID (ARMOUR THYROID) for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced EYELID THICKENING (Developed a little knot on the eye). At the time of the report, EYELID THICKENING (Developed a little knot on the eye) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in responsible to the events were not applicable No treatment information was provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash macular
Clinical narrative: Severe red streaks; Red blotches on palms of hand; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Severe red streaks) and RASH MACULAR (Red blotches on palms of hand) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Severe red streaks) and RASH MACULAR (Red blotches on palms of hand). On 10-Feb-2021, RASH ERYTHEMATOUS (Severe red streaks) and RASH MACULAR (Red blotches on palms of hand) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Mass, Migraine, Pain in extremity
Clinical narrative: swollen; red circle; Tiny little bumps; warm to the touch; Chills; Horrific migraine; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MIGRAINE (Horrific migraine), PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle) and MASS (Tiny little bumps) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 02SL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Atrial fibrillation and Arthritis.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Feb-2021, the patient experienced MIGRAINE (Horrific migraine) and CHILLS (Chills). On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle), MASS (Tiny little bumps) and VACCINATION SITE WARMTH (warm to the touch). On 26-Feb-2021, MIGRAINE (Horrific migraine) had resolved. On 27-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle), MASS (Tiny little bumps) and VACCINATION SITE WARMTH (warm to the touch) outcome was unknown.            Treatment included none concomitants -high blood pressure medicine, blood thinner   This case was linked to MOD-2021-030483 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site warmth
Clinical narrative: swollen; red circle; Tiny little bumps; warm to the touch; Chills; Horrific migraine; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MIGRAINE (Horrific migraine), PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle) and MASS (Tiny little bumps) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 02SL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Atrial fibrillation and Arthritis.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Feb-2021, the patient experienced MIGRAINE (Horrific migraine) and CHILLS (Chills). On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle), MASS (Tiny little bumps) and VACCINATION SITE WARMTH (warm to the touch). On 26-Feb-2021, MIGRAINE (Horrific migraine) had resolved. On 27-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (swollen), ERYTHEMA (red circle), MASS (Tiny little bumps) and VACCINATION SITE WARMTH (warm to the touch) outcome was unknown.            Treatment included none concomitants -high blood pressure medicine, blood thinner   This case was linked to MOD-2021-030483 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling hot, Myalgia, Rash, Tenderness
Clinical narrative: Rash above the right ankle up to six inches that is tender and hot to touch; Tenderness, Rash above the right ankle up to six inches that is tender and hot to touch; Diarrhea; Muscle pain; Rash above the right ankle up to six inches that is tender and hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Rash above the right ankle up to six inches that is tender and hot to touch), TENDERNESS (Tenderness, Rash above the right ankle up to six inches that is tender and hot to touch), DIARRHOEA (Diarrhea), MYALGIA (Muscle pain) and RASH (Rash above the right ankle up to six inches that is tender and hot to touch) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced FEELING HOT (Rash above the right ankle up to six inches that is tender and hot to touch), TENDERNESS (Tenderness, Rash above the right ankle up to six inches that is tender and hot to touch), DIARRHOEA (Diarrhea), MYALGIA (Muscle pain) and RASH (Rash above the right ankle up to six inches that is tender and hot to touch). At the time of the report, FEELING HOT (Rash above the right ankle up to six inches that is tender and hot to touch), TENDERNESS (Tenderness, Rash above the right ankle up to six inches that is tender and hot to touch), DIARRHOEA (Diarrhea), MYALGIA (Muscle pain) and RASH (Rash above the right ankle up to six inches that is tender and hot to touch) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not provided. Treatment information was not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Pain in extremity
Clinical narrative: Itchy Sensation - Near Injection Site; Redness - Near Injection Site; Rash - Near Injection Site; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 01-Mar-2021, the patient experienced INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site). On 21-Feb-2021, PAIN IN EXTREMITY (Arm pain) had resolved. At the time of the report, INJECTION SITE PRURITUS (Itchy Sensation - Near Injection Site), INJECTION SITE ERYTHEMA (Redness - Near Injection Site) and INJECTION SITE RASH (Rash - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment "Ointment" - Self medicating to try to alleviate the symptoms. No concomitants provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warmth; Pain at injection site; Itchy; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported    Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site pruritus
Clinical narrative: Tired or heavy feeling 5 days after 1st dose; Red itchy area at vaccine site after 1st dose; Red itchy area at vaccine site after 1st dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red itchy area at vaccine site after 1st dose), INJECTION SITE PRURITUS (Red itchy area at vaccine site after 1st dose) and FATIGUE (Tired or heavy feeling 5 days after 1st dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Red itchy area at vaccine site after 1st dose) and INJECTION SITE PRURITUS (Red itchy area at vaccine site after 1st dose). On 01-Mar-2021, the patient experienced FATIGUE (Tired or heavy feeling 5 days after 1st dose). At the time of the report, INJECTION SITE ERYTHEMA (Red itchy area at vaccine site after 1st dose) and INJECTION SITE PRURITUS (Red itchy area at vaccine site after 1st dose) had resolved and FATIGUE (Tired or heavy feeling 5 days after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) on 02-Mar-2021 for Headache, at an unspecified dose and frequency. On 02-Mar-2021, HEADACHE (headache) had resolved.            Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events were not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Swelling of eyelid
Clinical narrative: Light-headed; Headache; Swollen eyelids and the area below; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (Swollen eyelids and the area below), HEADACHE (Headache) and DIZZINESS (Light-headed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced SWELLING OF EYELID (Swollen eyelids and the area below). On 27-Feb-2021, the patient experienced HEADACHE (Headache). On 01-Mar-2021, the patient experienced DIZZINESS (Light-headed). At the time of the report, SWELLING OF EYELID (Swollen eyelids and the area below), HEADACHE (Headache) and DIZZINESS (Light-headed) outcome was unknown.            No concomitant medications or treatment details reported. Reported that all symptoms are ongoing and refused to give any other information because she was only seeking for medical advice about what to do and if she should go back to the ER.
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness in arm) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Soreness in arm). At the time of the report, MYALGIA (Soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Headache, Injection site pruritus, Injection site swelling, Rash
Clinical narrative: morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,; bruise at injection site; swollen at the injection site; headache; itchiness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache), INJECTION SITE PRURITUS (itchiness at the injection site), RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,) and CONTUSION (bruise at injection site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Blood disorder (Von-Willebrand.) and Drug allergy (Tylenol allergy). Concomitant products included VITAMINS NOS for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Feb-2021, the patient experienced INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache) and INJECTION SITE PRURITUS (itchiness at the injection site). On 28-Feb-2021, the patient experienced CONTUSION (bruise at injection site). On 01-Mar-2021, the patient experienced RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache), INJECTION SITE PRURITUS (itchiness at the injection site), RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,) and CONTUSION (bruise at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reported that patient called her doctor and sent her to an allergist. No other treatment details provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: redness, itching and rash on arm 2 weeks after 1st dose; redness, itching and rash on arm 2 weeks after 1st dose; redness, itching and rash on arm 2 weeks after 1st dose; A spontaneous report was received from a type concerning a 76-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness, itching and rash on arm 2 weeks after 1st dose.  The patient's medical history was not provided. Concomitant medications reported were tamoxifen, latanoprost, timolol, levothyroxine, crestor, baby aspirin, coenzyme q10, lisinopril, vitamin d, omega-3, proair for drug use for unknown indication.  On 13 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011mz0a) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) redness, itching and rash on arm 2 weeks after 1st dose.  Treatment details included Benadryl.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), redness, itching and rash on arm 2 weeks after 1st dose was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Influenza like illness, Myalgia
Clinical narrative: she felt bad but not that bad; severe muscle pain; fatigue; headaches; bad nausea; severe symptoms that were worse than the flu"; A spontaneous report () was received from a consumer concerning a 81-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced severe symptoms that were worse than the flu. She had severe muscle pain, fatigue, headaches, bad nausea, she felt bad but not that bad.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Feb 2021, prior to the onset of the events the patient received first dose of mRNA-1273 (lot/batch: 013A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 27 Feb 2021, the patient experienced the event(s) severe symptoms that were worse than the flu. She had severe muscle pain, fatigue, headaches, bad nausea for several hours. On 27 Feb 2021, the patient experienced the event(s) she felt bad but not that bad.  Treatment details included Tylenol and something for the nausea.  Action taken with mRNA-1273 in response to the events was not reported.  On28 Feb 2021 she felt good again.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: she felt bad but not that bad; severe muscle pain; fatigue; headaches; bad nausea; severe symptoms that were worse than the flu"; A spontaneous report () was received from a consumer concerning a 81-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced severe symptoms that were worse than the flu. She had severe muscle pain, fatigue, headaches, bad nausea, she felt bad but not that bad.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Feb 2021, prior to the onset of the events the patient received first dose of mRNA-1273 (lot/batch: 013A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 27 Feb 2021, the patient experienced the event(s) severe symptoms that were worse than the flu. She had severe muscle pain, fatigue, headaches, bad nausea for several hours. On 27 Feb 2021, the patient experienced the event(s) she felt bad but not that bad.  Treatment details included Tylenol and something for the nausea.  Action taken with mRNA-1273 in response to the events was not reported.  On28 Feb 2021 she felt good again.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Myalgia
Clinical narrative: Upper back muscle pains; Sore arm; A spontaneous report was received from a consumer concerning a female patient of 71-years-old,who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm, upper back muscle pains.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Mar 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 2 Mar 2021, the patient experienced the event(s) sore arm, upper back muscle pains.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of event(s), sore arm, upper back muscle pains was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Malaise, Nausea, Pain
Clinical narrative: felt ill; felt achy and nauseated but had no temperature; felt achy and nauseated but had no temperature; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt ill), PAIN (felt achy and nauseated but had no temperature) and NAUSEA (felt achy and nauseated but had no temperature) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced MALAISE (felt ill), PAIN (felt achy and nauseated but had no temperature) and NAUSEA (felt achy and nauseated but had no temperature). At the time of the report, MALAISE (felt ill), PAIN (felt achy and nauseated but had no temperature) and NAUSEA (felt achy and nauseated but had no temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Blood glucose increased: (Inconclusive) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were chemotherapy drug. No treatment information was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nausea, Pyrexia
Clinical narrative: headache; nausea; Fever  98.7 to 100; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (nausea) and PYREXIA (Fever  98.7 to 100) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Fever  98.7 to 100). On an unknown date, the patient experienced HEADACHE (headache) and NAUSEA (nausea). At the time of the report, HEADACHE (headache) and NAUSEA (nausea) had resolved and PYREXIA (Fever  98.7 to 100) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 98.7 to 100f (High) 98.7 to 100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypertension, Nausea, Pain in extremity
Clinical narrative: Blood pressure kind of high; Severe headache; very nauseated; light headed; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), HYPERTENSION (Blood pressure kind of high), DIZZINESS (light headed), HEADACHE (Severe headache) and NAUSEA (very nauseated) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included Ozempic, Lisinopril and ATORVASTATIN for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 28-Feb-2021, the patient experienced DIZZINESS (light headed) and NAUSEA (very nauseated). On 01-Mar-2021, the patient experienced HYPERTENSION (Blood pressure kind of high) and HEADACHE (Severe headache). At the time of the report, PAIN IN EXTREMITY (arm was sore), HYPERTENSION (Blood pressure kind of high), DIZZINESS (light headed), HEADACHE (Severe headache) and NAUSEA (very nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes simplex
Clinical narrative: Herpes simplex 1; This spontaneous case was reported by a health care professional and describes the occurrence of HERPES SIMPLEX (Herpes simplex 1) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VALSARTAN and METFORMIN for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced HERPES SIMPLEX (Herpes simplex 1). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) ongoing from 14-Feb-2021 at a dose of 1 dosage form. At the time of the report, HERPES SIMPLEX (Herpes simplex 1) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication also included Glycoside NOS.  As per follow up, patient states not being diagnosed with Herpes Simplex and no more information.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Significant information added-Event Outcome updated.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness
Clinical narrative: Flu like symptoms; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tired) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included BENAZEPRIL, ATORVASTATIN, PANTOPRAZOLE, OXYBUTYNIN HYDROCHLORIDE (OXYBUTININ ACCORD), VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL), HYDROCHLOROTHIAZIDE, ALENDRONATE SODIUM (FOSAMAX), CALCIUM, MAGNESIUM and VITAMIN D3 for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications Benazepril, Atorvastatin, Pantoprazole, oxybutynin, valacyclovir hcl , hydrochlorothiazide, Fosamax, Calcium, magnesium, vitamin D3  Treatment information was not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Influenza like illness, Night sweats, Pain in extremity
Clinical narrative: extreme pain in her arm  and legs/ arm hurt to touch; flue like symptoms; night sweat; extreme pain in her joints; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (extreme pain in her arm  and legs/ arm hurt to touch), INFLUENZA LIKE ILLNESS (flue like symptoms), NIGHT SWEATS (night sweat) and ARTHRALGIA (extreme pain in her joints) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (extreme pain in her arm  and legs/ arm hurt to touch), INFLUENZA LIKE ILLNESS (flue like symptoms), NIGHT SWEATS (night sweat) and ARTHRALGIA (extreme pain in her joints). At the time of the report, PAIN IN EXTREMITY (extreme pain in her arm  and legs/ arm hurt to touch), INFLUENZA LIKE ILLNESS (flue like symptoms), NIGHT SWEATS (night sweat) and ARTHRALGIA (extreme pain in her joints) outcome was unknown.            No relevant Concomitant medications were reported. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure fluctuation
Clinical narrative: Blood pressure went really high from the first vaccine and then fluctuated where now it's pretty low; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE FLUCTUATION (Blood pressure went really high from the first vaccine and then fluctuated where now it's pretty low) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immune thrombocytopenic purpura.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE FLUCTUATION (Blood pressure went really high from the first vaccine and then fluctuated where now it's pretty low). At the time of the report, BLOOD PRESSURE FLUCTUATION (Blood pressure went really high from the first vaccine and then fluctuated where now it's pretty low) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discharge
Clinical narrative: Small amount of leakage down her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (Small amount of leakage down her arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE DISCHARGE (Small amount of leakage down her arm). On 27-Feb-2021, VACCINATION SITE DISCHARGE (Small amount of leakage down her arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia
Clinical narrative: Arm Pain; SPike in fever of 100.8; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Arm Pain) and PYREXIA (SPike in fever of 100.8) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (Arm Pain) and PYREXIA (SPike in fever of 100.8). At the time of the report, PAIN (Arm Pain) and PYREXIA (SPike in fever of 100.8) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 100.8.         Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: 17 years old; A spontaneous report () was received from a healthcare professional concerning a 17-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event 17 years old. The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 010A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event 17 years old.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, 17 years old was considered to be resolved at the time of this report.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm is very sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is very sore) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm is very sore). At the time of the report, PAIN IN EXTREMITY (Arm is very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: Very bad numbness of the lower lip; A spontaneous report was received from a consumer, concerning a female patient of unspecified age, who received Moderna's COVID-19 vaccine and experienced very bad numbness of the lower lip (Hypoaesthesia oral). The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 01-Mar-2021, prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 (lot number unknown) via unknown route for COVID-19 infection prophylaxis. 27Feb2021 Patient visited physician and physician ruled out Bells Palsy. No treatment medication was reported. Action taken with mRNA-1273 in response to the event was not applicable. The outcome of the event, very bad numbness of the lower lip (Hypoaesthesia oral) was considered to be not resolved at the time of this report.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Experienced a warm feeling all over her arm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (Experienced a warm feeling all over her arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN WARM (Experienced a warm feeling all over her arm). At the time of the report, SKIN WARM (Experienced a warm feeling all over her arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  No treatment details were provided   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: follow up received on 13-07-2021 contain no new information
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at the injection site, Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site, Soreness at the injection site) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site, Soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site, Soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.